CHICO, Calif., Aug. 21, 2025 /PRNewswire/ — 24-time Grand Slam champion and Olympic gold medalist Novak Djokovic has acquired a significant stake in Incrediwear, the leader in bioactive infrared fabric technology, together marking a powerful new chapter in the future of athletic recovery and performance.
Djokovic discovered Incrediwear following his 2024 knee surgery and believes the company’s wearable technology played a role in his recovery. “I’m always looking for ways to support my performance and shorten recovery time,” said Djokovic.
Incrediwear’s clinically proven, element-infused fabric is activated by body heat to deliver infrared and negative ion therapy, accelerating recovery without drugs, compression, or side effects.
“When one of the world’s greatest athletes reaches out because our product made a difference, that’s the power of real results,” said Jackson Corley, founder and CEO of Incrediwear. “Novak shares our belief that recovery is the foundation of performance, and we’re proud to welcome him as both an investor and brand ambassador.”
Djokovic’s partnership represents a major milestone for Incrediwear as it scales its presence across sports, medical, and wellness sectors. His involvement will elevate global awareness, support expanded clinical research, and help drive innovation in therapeutic wearable technology.
About Incrediwear
Incrediwear is a pioneer in wearable therapeutic technology, using body-heat-activated fabrics infused with natural elements to increase circulation and reduce inflammation. Trusted by athletes, physicians, and wellness professionals worldwide, Incrediwear products are designed to accelerate recovery, enhance performance, and improve quality of life—without drugs or invasive treatments.
Contact:
Michael Bridges, 400108@email4pr.com, 415-209-8295
SOURCE Incrediwear
Atropos Health is integrating the American Society of Clinical Oncology® (ASCO®) Guidelines into their platform…
PLANO, Texas, Dec. 5, 2025 /PRNewswire/ -- Teams playing in the StaffDNA® Cure Bowl were…
IRVINE, Calif., Dec. 5, 2025 /PRNewswire/ -- The Dot Corp has expanded its services with…
CHICAGO, Dec. 5, 2025 /PRNewswire/ -- Vaniam Group™, a category leader redefining medical communications, announced…
The Life Sciences BPO Market is expanding rapidly, driven by rising R&D costs, increasing regulatory…
Results confirm reproducibility and research readiness for islet isolation of Biorep's next generation laboratory platform.MIAMI,…